Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$347K Buy
957
+50
+6% +$17.1K 0.07% 147
2026
Q1
$319K Buy
907
+158
+21% +$56.3K 0.08% 124
2025
Q4
$245K Buy
+749
New +$238K 0.06% 153

Other funds holding AMGN

55 North Private Wealth's AMGN Position: Q2 2026 in Review

55 North Private Wealth increased its Amgen (AMGN) stake by 5.5% in Q2 2026, buying an estimated $17.1K and bringing the position to 957 shares worth $347K. The position accounts for 0.07% of the portfolio, ranked #147.

55 North Private Wealth first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. 3,133 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • 55 North Private Wealth held 957 shares of Amgen worth $347K as of Q2 2026.
  • 55 North Private Wealth bought 50 Amgen shares in Q2 2026, an estimated $17.1K.
  • Amgen made up 0.07% of 55 North Private Wealth's portfolio in Q2 2026, its #147 holding.
  • 55 North Private Wealth first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
  • 3,133 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on 55 North Private Wealth's 13F filing for Q2 2026, filed 7 Jul 2026.